Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;24(1):22-32.
doi: 10.1177/1076029617734309. Epub 2017 Oct 9.

Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective

Carlos Cantú-Brito  1 , Gisele Sampaio Silva  2 , Sebastián F Ameriso  3
Affiliations
Review

Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective

Carlos Cantú-Brito et al. Clin Appl Thromb Hemost. 2018 Jan.

Abstract

Atrial fibrillation (AF) is a prominent risk factor for stroke and a leading cause of death and disability throughout Latin America. Contemporary evidence-based guidelines for the management of AF and stroke incorporate the use of practical and relatively simple scoring methods to estimate both stroke and bleeding risk, in order to assist in matching patients with appropriate interventions. This review examines consistencies and differences among guidelines for reducing stroke risk in patients with AF, assessing the role of user-friendly scoring methods to determine appropriate patients for anticoagulation and other treatment options. Current options include warfarin and direct oral anticoagulants such as dabigatran, rivaroxaban, apixaban, and edoxaban. These agents have been found to be superior or noninferior to standard vitamin K antagonist anticoagulation in large randomized trials. Potential benefits of these agents mainly include lower ischemic stroke rates, reduced intracranial bleeding, no need for regular monitoring, and fewer drug-drug and drug-food interactions. Expert opinions regarding clinical situations for which data are presently lacking, such as emergency bleeding and stroke in anticoagulated patients, are also provided. Enhanced attention and adherence to evidence-based guidelines are essential components for a strategy to reduce stroke morbidity and mortality across Latin America.

Keywords: Latin America; evidence-based guidelines; nonvalvular atrial fibrillation.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: C.C.-B. reports consulting fees, advisory boards, travel support, and clinical trials participation from Sanofi, Boehringer Ingelheim, Bayer, Pfizer, AstraZeneca, and Servier. G.S.S. reports consulting fees, advisory boards, travel support, and clinical trials participation from Bristol-Myers Squibb, Bayer, Pfizer, and AstraZeneca. S.F.A. reports consulting fees, advisory boards, travel support, and clinical trials participation from Sanofi, Boehringer Ingelheim, Bayer, Pfizer, Bristol-Myers Squibb, AstraZeneca, Merck, and Servier.

Figures

Figure 1.
Figure 1.
Stroke risk in patients with NVAF by 2 common scoring methods. A, Stroke risk by CHADS2 score in patients with NVAF. Based on data from Gage et al. B, Stroke risk by CHA2DS2-VASc score in patients with NVAF. Based on data from Lip et al. NVAF indicates nonvalvular atrial fibrillation; TIA, transient ischemic attack. aPrior myocardial infarction, peripheral artery disease, or aortic plaque.
Figure 2.
Figure 2.
Bleeding risk in patients with NVAF estimated by 2 scoring methods. A, Bleeding risk according to HAS-BLED score. Based on data from Friberg et al. B, Bleeding risk according to ORBIT score. Based on data from O’Brien et al. Hct indicates hematocrit; INR, international normalized ratio; NVAF, nonvalvular atrial fibrillation; OAC, oral anticoagulant.
See this image and copyright information in PMC

References

    1. de Carvalho JJ, Alves MB, Viana GA, et al. Stroke epidemiology, patterns of management, and outcomes in Fortaleza, Brazil: a hospital-based multicenter prospective study. Stroke. 2011;42(12):3341–3346. - PubMed
    1. Porcello Marrone LC, Diogo LP, de Oliveira FM, et al. Risk factors among stroke subtypes in Brazil. J Stroke Cerebrovasc Dis. 2013;22(1):32–35. - PubMed
    1. Saposnik G, Del Brutto OH. Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke. 2003;34(9):2103–2107. - PubMed
    1. Marquez-Romero JM, Arauz A, Gongora-Rivera F, Barinagarrementeria F, Cantu C. The burden of stroke in Mexico. Int J Stroke. 2015;10(2):251–252. - PubMed
    1. Cantu-Brito C, Majersik JJ, Sanchez BN, et al. Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the brain attack surveillance in Durango study. Stroke. 2011;42(3):601–606. - PMC - PubMed

LinkOut - more resources